Run‐in periods and clinical outcomes of antipsychotics in dementia: A meta‐epidemiological study of placebo‐controlled trials

Tekijä Hulshof, Tessa A., Zuidema, Sytse U., Gispen‐de Wied, Christine C., Luijendijk, Hendrika J.
Julkaisussa Pharmacoepidemiol Drug Saf (2019)

Future of the drug label: Perspectives from a multistakeholder dialogue

Tekijä Gispen‐de Wied, Christine C., Weemers, Just, Boon, Wouter, Mol, Peter G.M., Stolk, Pieter
Julkaisussa Br J Clin Pharmacol (2019)

Regulatory scientific advice in drug development: does company size make a difference?

Tekijä Putzeist, Michelle, Mantel-Teeuwisse, Aukje K., Gispen-De Wied, Christine C., Hoes, Arno W., Leufkens, Hubert G.
Julkaistu 2010

Oncologic orphan drugs approved in the EU – do clinical trial data correspond with real-world effectiveness?

Tekijä Schuller, Yvonne, Biegstraaten, Marieke, Hollak, Carla E. M., Klümpen, Heinz-Josef, Gispen-de Wied, Christine C., Stoyanova-Beninska, Violeta
Julkaisussa Orphanet J Rare Dis (2018)

Baseline imbalances and clinical outcomes of atypical antipsychotics in dementia: A meta‐epidemiological study of randomized trials

Tekijä Hulshof, Tessa A., Zuidema, Sytse U., van Meer, Peter J.K., Gispen‐de Wied, Christine C., Luijendijk, Hendrika J.
Julkaisussa Int J Methods Psychiatr Res (2018)

Drug Shortages From the Perspectives of Authorities and Pharmacy Practice in the Netherlands: An Observational Study

Tekijä Postma, Doerine J., De Smet, Peter A. G. M., Gispen-de Wied, Christine C., Leufkens, Hubert G. M., Mantel-Teeuwisse, Aukje K.
Julkaisussa Front Pharmacol (2018)

Alignment of European Regulatory and Health Technology Assessments: A Review of Licensed Products for Alzheimer's Disease

Tekijä Dekker, Marieke J. H. J., Bouvy, Jacoline C., O'Rourke, Diana, Thompson, Robin, Makady, Amr, Jonsson, Pall, Gispen-de Wied, Christine C.
Julkaisussa Front Med (Lausanne) (2019)

Immunogenicity of mAbs in non-human primates during nonclinical safety assessment

Tekijä van Meer, Peter J.K., Kooijman, Marlous, Brinks, Vera, Gispen-de Wied, Christine C., Silva-Lima, Beatriz, Moors, Ellen H.M., Schellekens, Huub
Julkaistu 2013

Requirements for generic anti-epileptic medicines: a regulatory perspective

Tekijä Maliepaard, Marc, Hekster, Yechiel A., Kappelle, Arnoud, van Puijenbroek, Eugène P., Elferink, André J., Welink, Jan, Gispen-de Wied, Christine C., Lekkerkerker, Frits J. F.
Julkaistu 2009

A standardised framework to identify optimal animal models for efficacy assessment in drug development

Tekijä S. Ferreira, Guilherme, Veening-Griffioen, Désirée H., Boon, Wouter P. C., Moors, Ellen H. M., Gispen-de Wied, Christine C., Schellekens, Huub, van Meer, Peter J. K.
Julkaisussa PLoS One (2019)

Correction: A standardised framework to identify optimal animal models for efficacy assessment in drug development

Tekijä Ferreira, Guilherme S., Veening-Griffioen, Désirée H., Boon, Wouter P. C., Moors, Ellen H. M., Gispen-de Wied, Christine C., Schellekens, Huub, van Meer, Peter J. K.
Julkaisussa PLoS One (2019)

Regulatory Scientific Advice on Non-Inferiority Drug Trials

Tekijä Wangge, Grace, Putzeist, Michelle, Knol, Mirjam J., Klungel, Olaf H., Gispen-De Wied, Christine C., de Boer, Antonius, Hoes, Arno W., Leufkens, Hubert G., Mantel-Teeuwisse, Aukje K.
Julkaistu 2013

Impaired Neuroendocrine and Immune Response to Acute Stress in Medication-Naive Patients With a First Episode of Psychosis

Tekijä van Venrooij, Janine A. E .M., Fluitman, Sjoerd B. A. H. A., Lijmer, Jeroen G., Kavelaars, Annemieke, Heijnen, Cobi J., Westenberg, Herman G. M., Kahn, René S., Gispen-de Wied, Christine C.
Julkaistu 2012

Sex Proportionality in Pre-clinical and Clinical Trials: An Evaluation of 22 Marketing Authorization Application Dossiers Submitted to the European Medicines Agency

Tekijä Dekker, Marieke J. H. J., de Vries, Sieta T., Versantvoort, Carolien H. M., Drost-van Velze, Ellen G. E., Bhatt, Mansi, van Meer, Peter J. K., Havinga, Ineke K., Gispen-de Wied, Christine C., Mol, Peter G. M.
Julkaisussa Front Med (Lausanne) (2021)